Page 3 - Best oncologists in Israel: TOP 112 doctors

Director of Surgical Residency at Hadassah Medical Center, Dr. Pikarsky trains future surgeons in complex colorectal procedures.

• 39 years of experience of experience in surgery and colorectal specialties
• Senior lecturer in surgery at Hebrew University since 2005
• Board-certified in general surgery with subspecialty in colorectal surgery
• Active member of multiple respected surgical associations

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center – specializing in complex digestive cancers with 36 years of experience of experience.

• Board-certified in both oncology and radiotherapy
• Specializes in proton-beam therapy and immunotherapy for GI cancers
• Member of Israel Society of Clinical Oncology and Cancer Association
• Fluent in English and Hebrew for international patients

Prof. Dr. Reuven Or is a leading hematologist and bone marrow transplant specialist at Hadassah Medical Center, awarded the Menachem Begin Prize for his contributions.

• of experience in hematology and bone marrow transplantation
• Head of Hematology and Bone Marrow Transplantation at Hadassah
• Medical Director of Israel's National Blood Bank
• Published multiple articles in medical journals

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Specializes in advanced thyroid cancer and head & neck tumors with personalized biological therapy at Hadassah Medical Center.

• Director of Oncology at Hadassah – one of Israel's top cancer centers
• Fellowship-trained at Memorial Sloan Kettering in radiosurgery techniques
• 23 years of experience focused on head & neck oncology and radiotherapy
• Former Head of Head & Neck Oncology at Davidoff Cancer Center

Leading researcher in BRCA-related breast cancer – Dr. Kaduri specializes in genetic mutations at Hadassah Medical Center.

• Conducted groundbreaking research at The Royal Marsden Hospital
• Published on Oncotype Dx in BRCA1/2 carriers
• Awarded the Cancer Genetics Research Foundation Award
• Member of the Israeli Society of Clinical Oncology

Dr. Rinat Erushalmi specializes in treating challenging breast cancer subtypes at Rabin Medical Center, Israel's leading oncology hospital.

• Expert in HER-2 Positive and Triple-Negative Breast Cancer
• Highly rated by patients in 6 conditions
• Specializes in hormone-related treatments and risk-reducing surgeries
• Practices at Rabin Medical Center – Israel's largest cancer center

Heads the oncological surgery department at Rabin Medical Center – Dr. Nejman leads advanced clinical studies in oncourology.

• specializing in urological and breast cancers
• Leads numerous international clinical trials for new treatments
• Frequently invited speaker at major oncology forums
• Member of multiple international oncology societies

Professor Ami Fishman specializes in minimally invasive endoscopic and laparoscopic surgeries for gynecologic cancers at Herzliya Medical Center.

• Head of Obstetrics and Gynecology at Meir Medical Center
• Expert in treating ovarian, uterine, and cervical cancers
• Leads the oncogynecology team at Herzliya Medical Center
• Specializes in minimally invasive surgical techniques

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Recipient of the prestigious ASCO MERIT Award for clinical research
• Chairs IASLC's Early Detection & Prevention Committee
• Fellowship-trained in lung cancer at University of Colorado Denver
• Focuses on personalized medicine and novel diagnostic technologies

Urologist, Surgeon

Professor Jablonski-Perec trained at Sloan-Kettering Cancer Center – one of the world's top oncology institutions – and leads the Institute of Oncology at Hadassah Medical Center.

• Head of Breast Cancer Treatment Center since 1998
• Professor of Oncology at Hebrew University
• Member of several international cancer communities
• Awarded scholarship from Hadassah Medical School